Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity

SARS-CoV-2 spike mRNA vaccines have shown remarkable clinical efficacy in the general population, although the nature of T-cell priming is not fully understood. We performed longitudinal spike-, membrane-, and nucleocapsid-specific T-cell analysis in individuals with past infection and infection-naï...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallejo, Alejandro, Martín-Hondarza, Adrián, Gómez, Sandra, Velasco, Héctor, Vizcarra, Pilar, Haemmerle, Johannes, Casado, José L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874124/
https://www.ncbi.nlm.nih.gov/pubmed/35222312
http://dx.doi.org/10.3389/fmicb.2021.812729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874124/
https://www.ncbi.nlm.nih.gov/pubmed/35222312
http://dx.doi.org/10.3389/fmicb.2021.812729

Ejemplares similares